SURI
PT Maja Agung Latexindo Tbk engages in the manufacture and sale of gloves in Indonesia. The company offers examination gloves, industrial gloves, and specialty gloves; and concentrated latex. It serves the medical and healthcare, industrial, and beauty care industries. The company also exports its products. PT Maja Agung Latexindo Tbk was founded in 1988 and is based in Deli Serdang, Indonesia.
SURI (SURI) - Net Assets
Latest net assets as of June 2025: Rp344.55 Billion IDR
Based on the latest financial reports, SURI (SURI) has net assets worth Rp344.55 Billion IDR as of June 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Rp394.35 Billion) and total liabilities (Rp49.80 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | Rp344.55 Billion |
| % of Total Assets | 87.37% |
| Annual Growth Rate | 50.55% |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 95.77 |
SURI - Net Assets Trend (2020–2024)
This chart illustrates how SURI's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for SURI (2020–2024)
The table below shows the annual net assets of SURI from 2020 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | Rp343.17 Billion | -0.98% |
| 2023-12-31 | Rp346.57 Billion | +235.04% |
| 2022-12-31 | Rp103.44 Billion | +10.92% |
| 2021-12-31 | Rp93.26 Billion | +39.59% |
| 2020-12-31 | Rp66.81 Billion | -- |
Equity Component Analysis
This analysis shows how different components contribute to SURI's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 77.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | Rp7.46 Billion | 2.17% |
| Common Stock | Rp126.69 Billion | 36.92% |
| Other Components | Rp209.02 Billion | 60.91% |
| Total Equity | Rp343.17 Billion | 100.00% |
SURI Competitors by Market Cap
The table below lists competitors of SURI ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Sherborne Investors Guernsey C Ltd
LSE:SIGC
|
$39.53 |
|
FutureNet Inc
PINK:FUUN
|
$39.56 |
|
GEO JS Tech Group Corp
PINK:GJST
|
$39.58 |
|
DKHH
JK:DKHH
|
$39.67 |
|
WorldCall Telecom Ltd
KAR:WTL
|
$39.24 |
|
BRICLINKS AFRICA PLC
XNSA:BAPLC
|
$39.24 |
|
Agri-Dynamics Inc
PINK:AGDY
|
$39.23 |
|
ABC TRANSPORT PLC
XNSA:ABCTRANS
|
$39.17 |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in SURI's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 346,572,800,000 to 343,168,679,000, a change of -3,404,121,000 (-1.0%).
- Net loss of 3,873,515,000 reduced equity.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | Rp-3.87 Billion | -1.13% |
| Other Changes | Rp469.39 Million | +0.14% |
| Total Change | Rp- | -0.98% |
Book Value vs Market Value Analysis
This analysis compares SURI's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.90x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has decreased from 6.26x to 0.90x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2020-12-31 | Rp10.55 | Rp66.00 | x |
| 2021-12-31 | Rp14.72 | Rp66.00 | x |
| 2022-12-31 | Rp16.33 | Rp66.00 | x |
| 2023-12-31 | Rp74.33 | Rp66.00 | x |
| 2024-12-31 | Rp73.60 | Rp66.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently SURI utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -1.13%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -3.32%
- • Asset Turnover: 0.29x
- • Equity Multiplier: 1.16x
- Recent ROE (-1.13%) is below the historical average (16.36%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2020 | 43.14% | 9.20% | 1.42x | 3.31x | Rp22.14 Billion |
| 2021 | 28.34% | 7.82% | 1.56x | 2.32x | Rp17.10 Billion |
| 2022 | 9.89% | 10.96% | 0.50x | 1.82x | Rp-118.08 Million |
| 2023 | 1.58% | 6.69% | 0.20x | 1.18x | Rp-29.19 Billion |
| 2024 | -1.13% | -3.32% | 0.29x | 1.16x | Rp-38.19 Billion |
Industry Comparison
This section compares SURI's net assets metrics with peer companies in the Medical Instruments & Supplies industry.
Industry Context
- Industry: Medical Instruments & Supplies
- Average net assets among peers: $406,922,931,319
- Average return on equity (ROE) among peers: 62.87%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| SURI (SURI) | Rp344.55 Billion | 43.14% | 0.14x | $39.35 |
| Mark Dynamics Indonesia Tbk PT (MARK) | $237.74 Billion | 34.45% | 0.34x | $36.64 Million |
| PT Hetzer Medical Indonesia Tb (MEDS) | $32.46 Billion | 82.03% | 0.54x | $2.39 Million |
| Jayamas Medica Industri (OMED) | $950.57 Billion | 72.12% | 0.49x | $62.25 Million |